Rehaler A/S (Under frivillig likvidation)Aktiv

Description of key activities of the company Like previous years, the activities are to develop and commercialize innovative treatments for patients suffering from migraine.

Significant changes in the company's activities and financial matters The board has decided to begin a liquidation of the company. Income or loss from ordinary activities after tax totals DKK -7.645.019 against DKK -5.381.224 last year. Management considers the net profit or loss for the year unsatisfactory. The most significant modifications resulting from the liquidation Assets and equity and liabilities have been measured at realisable values. As a result of the liquidation, all assets have been recognised under current assets whereas all liabilities other than provisions are recognised as short-term payables. Consequently, the measurements of assets and equity and liabilities are not comparable with last year’s measurements. All value adjustments of assets and equity and liabilities and any operating items in connection with the commencement of the liquidation have been recognised in the income statement, including staff commitments arising from dismissal, liquidator and auditor fees, and other fees relative to the liquidation. The company’s equity is measured at the net realisable value and referred to as the liquidation account. The amount of the liquidation account corresponds to the amount distributed to the shareholders. Except for the changes mentioned above, the accounting policies are unchanged from previous years. The change in accounting policy have the following effect on current years profit or loss, DKK - 171.509 and the following effect on equity, DKK -171.5

Uddrag af ledelsesberetningen i den seneste årsrapport.